ingredients in tirzepatide (Zepbound, Mounjaro): Weight Loss, Diabetes, Dosage & Side Effects Compounded Tirzepatide Explained: Key Facts

SOURCE American Academy of Orthopaedic Surgeons

Marketed as Mounjaro for the treatment of type 2 diabetes, the drug was subsequently approved as Zepbound for obesity by the FDA in November 2023

Since no other drug in the market offers proven cardiac benefits along with weight loss (including Eli Lillys), it is safe to say that Novo Nordisk is way ahead in the race and will dominate the market for the foreseeable future

We conclude that the evidence is in favor of multivitamins being a reliable source

Case Report: Secondary Hemophagocytic Lymphohistiocytosis with Disseminated Infection in Chronic Granulomatous Disease-A Serious Cause of Mortality

Postgraduate Medicine , 127 (8), 818826